IDO1 and neoplasm: In a B16 melanoma mouse model expressing IDO, it has been shown that the blockade of colony stimulating factor 1 receptor (CSF-1R) by the kinase inhibitor PLX647 could inhibit tumor-infiltrating MDSC and enhance anti-tumor T cell responses (92).